Literature DB >> 24076372

p53 Suppresses E2F1-dependent PLK1 expression upon DNA damage by forming p53-E2F1-DNA complex.

Zhe Zhou1, Ji-Xiang Cao, Shu-Yan Li, Guo-Shun An, Ju-Hua Ni, Hong-Ti Jia.   

Abstract

E2F1 is implicated in transcriptional activation of polo-like kinase-1 (PLK1), but yet the mechanism is not fully understood. PLK1 suppression plays an important checkpoint role in response to DNA damage. Suppression of the PLK1 gene by binding of p53 to upstream p53RE2 element in the promoter has been recently revealed. Here we report another mechanism, in which p53 interacts with E2F1 to form p53-E2F1-DNA complex repressing E2F1-dependent PLK1 expression. PLK1 was downregulated in cisplatin exposed HCT116p53(+/+) but not HCT116p53(-/-) cells, indicating p53-suppressed PLK1 upon DNA damage. Co-transfection and reporter enzyme assays revealed that p53 suppressed but E2F1 promoted PLK1 gene activation. 5'-Deletion and substitution mutations showed multiple positive cis-elements residing in the PLK1 promoter, of which at least two E2F1 sites at positions -75/-68 and -40/-32 were required for the full activity of the promoter. Combination of 5'-deletion and substitution mutations with over-expression of p53 showed that suppression of the PLK1 gene by p53 was E2F1-dependent: mutation of the E2F1 site at position -75/-68 partially abrogated suppression activity of p53; mutation of E2F1 site at position -40/-32 released from p53 suppression of PLK1 gene completely. Co-immunoprecipitation and electrophoretic mobility shift assay showed that DNA damage promoted p53-E2F1 interaction, thereby creating a p53-E2F1 complex assembly on the PLK1 promoter in vitro. The in vivo formation of p53-E2F1-PLK1 promoter complex upon DNA damage was further evidenced by chromatin immunoprecipitation (ChIP) and re-ChIP. In addition, we showed that suppression of PLK1 by p53 promoted apoptosis. Our data suggest that p53 may interact with E2F1 to form p53-E2F1-DNA complex suppressing E2F1-dependent PLK1 expression. The model of p53 action on E2F1-activated PLK1 gene may explain at least partly how p53 as a suppressor regulates the downstream effects of E2F1 in cellular stresses including DNA damage stress.
© 2013 Published by Elsevier Inc.

Entities:  

Keywords:  DNA damage; E2F1; PLK1; Transcription regulation; p53

Mesh:

Substances:

Year:  2013        PMID: 24076372     DOI: 10.1016/j.yexcr.2013.09.012

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  16 in total

1.  E2F1 regulates p53R2 gene expression in p53-deficient cells.

Authors:  Jun-Juan Qi; Ling Liu; Ji-Xiang Cao; Guo-Shun An; Shu-Yan Li; Gang Li; Hong-Ti Jia; Ju-Hua Ni
Journal:  Mol Cell Biochem       Date:  2014-10-14       Impact factor: 3.396

2.  ATM-dependent E2F1 accumulation in the nucleolus is an indicator of ribosomal stress in early response to DNA damage.

Authors:  Ya-Qiong Jin; Guo-Shun An; Ju-Hua Ni; Shu-Yan Li; Hong-Ti Jia
Journal:  Cell Cycle       Date:  2014-03-25       Impact factor: 4.534

Review 3.  Transcription factors that interact with p53 and Mdm2.

Authors:  Kazushi Inoue; Elizabeth A Fry; Donna P Frazier
Journal:  Int J Cancer       Date:  2015-07-14       Impact factor: 7.396

4.  E2F2 promotes lung adenocarcinoma progression through B-Myb- and FOXM1-facilitated core transcription regulatory circuitry.

Authors:  Kailong Du; Shijie Sun; Tinghui Jiang; Tao Liu; Xiaofeng Zuo; Xing Xia; Xianjun Liu; Yitao Wang; Youquan Bu
Journal:  Int J Biol Sci       Date:  2022-06-25       Impact factor: 10.750

5.  MiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cells.

Authors:  J-X Cao; Y Lu; J-J Qi; G-S An; Z-B Mao; H-T Jia; S-Y Li; J-H Ni
Journal:  Cell Death Dis       Date:  2014-09-25       Impact factor: 8.469

6.  The transcription factor p53: not a repressor, solely an activator.

Authors:  Martin Fischer; Lydia Steiner; Kurt Engeland
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 7.  Polo-like kinase-1 in DNA damage response.

Authors:  Sun-Yi Hyun; Hyo-In Hwang; Hyo-In Hwan; Young-Joo Jang
Journal:  BMB Rep       Date:  2014-05       Impact factor: 4.778

8.  Combinatorial inhibition of Plk1 and PKCβ in cancer cells with different p53 status.

Authors:  Lisa Lange; Sarah Keppner-Witter; Juline Grigat; Birgit Spänkuch
Journal:  Oncotarget       Date:  2014-04-30

9.  Increased Expression of Phosphorylated Polo-Like Kinase 1 and Histone in Bypass Vein Graft and Coronary Arteries following Angioplasty.

Authors:  Swastika Sur; Vicki J Swier; Mohamed M Radwan; Devendra K Agrawal
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

10.  Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.

Authors:  Martin Fischer; Marianne Quaas; Annina Nickel; Kurt Engeland
Journal:  Oncotarget       Date:  2015-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.